Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 10471-10475 [2020-03612]

Download as PDF 10471 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA registered researchers. If its application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a Bulk Manufacturer of Marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a) as described in 84 FR 44920, published on August 27, 2019. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on May 30, 2019, Irvine Labs, Inc., 1864 Swan Circle, Costa Mesa, California 92626–4739 applied to be registered as a bulk manufacturer of the following basic class of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Marihuana Extract .. Marihuana ............... Tetrahydrocannabinols. Drug code 7350 7360 7370 Schedule I I I The applicant noticed above applied to become registered with DEA to grow marihuana as bulk manufacturer subsequent to a 2016 DEA policy statement that provided information on how it intended to expand the number of registrations, and described in general terms the way it would oversee those additional growers. Before DEA completes the evaluation and registration process for applicants to grow marihuana, DEA intends to propose regulations in the near future that would supersede the 2016 policy statement and govern persons seeking to become registered with DEA to grow marihuana as bulk manufacturers, consistent with applicable law, as described in 84 FR 44920. Dated: February 3, 2020. William T. McDermott, Assistant Administrator. Gamma Hydroxybutyric Acid. lotter on DSKBCFDHB2PROD with NOTICES Jkt 250001 2010 I I I Dated: January 31, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020–03617 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2020–03623 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–595] [Docket No. DEA–585] Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc. ACTION: Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC ACTION: Notice of application. Notice of application. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: In accordance with 21 CFR 1301.33(a), this is notice that on December 23, 2019, Patheon Pharmaceuticals, Inc., 2100 E Galbraith Road, Cincinnati, Ohio 45237–1625 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance: SUPPLEMENTARY INFORMATION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on January 9, 2020, Chemtos, LLC, 16713 Picadilly Court, Round Rock, Texas 78664–8544 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Drug code 3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................................... Cathinone ................................................................................................................................................................................ Methcathinone ......................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................................... Pentedrone (a-methylaminovalerophenone) ........................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................................ 4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................................... 18:30 Feb 21, 2020 Schedule The Gamma Hydroxbutyric Acid will be produced during the process of converting gamma-butyrolactone into a new product for development. The company plans to manufacture the above-listed controlled substance as Active Pharmaceutical Ingredient (API) that will be further synthesized into dosage forms of a new product. No other activities for this drug code are authorized for this registration. Controlled substance VerDate Sep<11>2014 Drug code Controlled substance PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 1233 1235 1237 1238 1246 1248 1249 Schedule I I I I I I I 10472 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Drug code lotter on DSKBCFDHB2PROD with NOTICES Controlled substance Naphyrone ............................................................................................................................................................................... N-Ethylamphetamine ............................................................................................................................................................... N,N-Dimethylamphetamine ...................................................................................................................................................... Fenethylline ............................................................................................................................................................................. Aminorex .................................................................................................................................................................................. 4-Methylaminorex (cis isomer) ................................................................................................................................................ Gamma Hydroxybutyric Acid ................................................................................................................................................... Methaqualone .......................................................................................................................................................................... Mecloqualone .......................................................................................................................................................................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................................... SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................................ ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................ AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................. FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ....................................................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................................. MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............................. FUB–AMB, MMB-FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ... AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................. THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ........................................................................... 5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................ AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ......................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................ 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ...................................................... 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............. ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................................. 5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ...................................... MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .. MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ................ FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide). APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ...................................................................... 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .......................................... JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................................... 5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ............................ 5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ....................... 4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide). SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................................ JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................... JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................. UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ................................................................................................................ JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ............................................................................................................... NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate .................................................................. PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................................... 4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) ............................................................................................................. N-Ethylhexedrone .................................................................................................................................................................... Alpha-ethyltryptamine .............................................................................................................................................................. Ibogaine ................................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................................ CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .................................................. Lysergic acid diethylamide ...................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................................... Marihuana Extract ................................................................................................................................................................... Marihuana ................................................................................................................................................................................ Parahexyl ................................................................................................................................................................................. Mescaline ................................................................................................................................................................................. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................................. 3,4,5-Trimethoxyamphetamine ................................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................................... JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................................. 2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................................ 3,4-Methylenedioxyamphetamine ............................................................................................................................................ 5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................................... VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 Schedule 1258 1475 1480 1503 1585 1590 2010 2565 2572 6250 7008 7010 7011 7012 7014 7019 7020 7021 7023 7024 7025 7031 7032 7033 7034 7035 7036 7041 7042 7044 7047 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 7048 7049 7081 7083 7085 7089 I I I I I I 7104 7118 7122 7144 7173 7200 7201 7203 7221 7222 7225 7245 7246 7249 7260 7297 7298 7315 7348 7350 7360 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 10473 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Drug code lotter on DSKBCFDHB2PROD with NOTICES Controlled substance 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................................... 4-Methoxyamphetamine .......................................................................................................................................................... 5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................................ Alpha-methyltryptamine ........................................................................................................................................................... Bufotenine ................................................................................................................................................................................ Diethyltryptamine ..................................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................................. Psilocybin ................................................................................................................................................................................. Psilocyn ................................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................................... 4’-Chloro-alpha-pyrrolidinovalerophenone ............................................................................................................................... MPHP, 4’-Methyl-alpha-pyrrolidinohexiophenone ................................................................................................................... N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................................ 1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................................... N-Ethyl-3-piperidyl benzilate .................................................................................................................................................... N-Methyl-3-piperidyl benzilate ................................................................................................................................................. N-Benzylpiperazine .................................................................................................................................................................. 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ............................................................................................................. 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C–D) ........................................................................................................... 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C–E ) ............................................................................................................. 2-(2,5-Dimethoxyphenyl)ethanamine (2C–H) .......................................................................................................................... 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C–I) ................................................................................................................. 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C–C) ........................................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C–N) ............................................................................................................. 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C–P) ...................................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C–T–4 ) ............................................................................................ MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B–NBOMe) ............................................................. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C–NBOMe) ............................................................. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I–NBOMe) .................................................................. Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................................. Butylone ................................................................................................................................................................................... Pentylone ................................................................................................................................................................................. N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ............................................................. a-PHP, alpha-Pyrrolidinohexanophenone ............................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) ............................................................................................................ Acetyldihydrocodeine ............................................................................................................................................................... Benzylmorphine ....................................................................................................................................................................... Codeine-N-oxide ...................................................................................................................................................................... Cyprenorphine ......................................................................................................................................................................... Desomorphine ......................................................................................................................................................................... Etorphine (except HCl) ............................................................................................................................................................ Codeine methylbromide ........................................................................................................................................................... Dihydromorphine ..................................................................................................................................................................... Difenoxin .................................................................................................................................................................................. Heroin ...................................................................................................................................................................................... Hydromorphinol ....................................................................................................................................................................... Methyldesorphine .................................................................................................................................................................... Methyldihydromorphine ........................................................................................................................................................... Morphine methylbromide ......................................................................................................................................................... Morphine methylsulfonate ....................................................................................................................................................... Morphine-N-oxide .................................................................................................................................................................... Myrophine ................................................................................................................................................................................ Nicocodeine ............................................................................................................................................................................. Nicomorphine ........................................................................................................................................................................... Normorphine ............................................................................................................................................................................ Pholcodine ............................................................................................................................................................................... Thebacon ................................................................................................................................................................................. Acetorphine .............................................................................................................................................................................. Drotebanol ............................................................................................................................................................................... U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................................... AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .......................................................................... MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .......................................................................................................... Acetylmethadol ........................................................................................................................................................................ Allylprodine .............................................................................................................................................................................. Alphacetylmethadol except levo-alphacetylmethadol .............................................................................................................. Alphameprodine ....................................................................................................................................................................... Alphamethadol ......................................................................................................................................................................... VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7443 7446 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7694 9051 9052 9053 9054 9055 9056 9070 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 9547 9551 9560 9601 9602 9603 9604 9605 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 10474 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Drug code lotter on DSKBCFDHB2PROD with NOTICES Controlled substance Benzethidine ............................................................................................................................................................................ Betacetylmethadol ................................................................................................................................................................... Betameprodine ........................................................................................................................................................................ Betamethadol ........................................................................................................................................................................... Betaprodine ............................................................................................................................................................................. Clonitazene .............................................................................................................................................................................. Dextromoramide ...................................................................................................................................................................... Diampromide ........................................................................................................................................................................... Diethylthiambutene .................................................................................................................................................................. Dimenoxadol ............................................................................................................................................................................ Dimepheptanol ......................................................................................................................................................................... Dimethylthiambutene ............................................................................................................................................................... Dioxaphetyl butyrate ................................................................................................................................................................ Dipipanone ............................................................................................................................................................................... Ethylmethylthiambutene .......................................................................................................................................................... Etonitazene .............................................................................................................................................................................. Etoxeridine ............................................................................................................................................................................... Furethidine ............................................................................................................................................................................... Hydroxypethidine ..................................................................................................................................................................... Ketobemidone .......................................................................................................................................................................... Levomoramide ......................................................................................................................................................................... Levophenacylmorphan ............................................................................................................................................................ Morpheridine ............................................................................................................................................................................ Noracymethadol ....................................................................................................................................................................... Norlevorphanol ........................................................................................................................................................................ Normethadone ......................................................................................................................................................................... Norpipanone ............................................................................................................................................................................ Phenadoxone ........................................................................................................................................................................... Phenampromide ...................................................................................................................................................................... Phenoperidine .......................................................................................................................................................................... Piritramide ................................................................................................................................................................................ Proheptazine ............................................................................................................................................................................ Properidine .............................................................................................................................................................................. Racemoramide ........................................................................................................................................................................ Trimeperidine ........................................................................................................................................................................... Phenomorphan ........................................................................................................................................................................ Propiram .................................................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine .............................................................................................................................. 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ...................................................................................................................... Tilidine ..................................................................................................................................................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................................... Para-Fluorofentanyl ................................................................................................................................................................. 3-Methylfentanyl ...................................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................................... Acetyl-alpha-methylfentanyl ..................................................................................................................................................... N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................................... Butyryl Fentanyl ....................................................................................................................................................................... Para-fluorobutyryl fentanyl ....................................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ................................................................................................. Para-chloroisobutyryl fentanyl ................................................................................................................................................. Isobutyryl fentanyl .................................................................................................................................................................... Beta-hydroxyfentanyl ............................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ................................................................................................................................................ Alpha-methylthiofentanyl ......................................................................................................................................................... 3-Methylthiofentanyl ................................................................................................................................................................. Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................................... Thiofentanyl ............................................................................................................................................................................. Beta-hydroxythiofentanyl ......................................................................................................................................................... Para-methoxybutyryl fentanyl .................................................................................................................................................. Para-methoxybutyryl fentanyl .................................................................................................................................................. Valeryl fentanyl ........................................................................................................................................................................ N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................. Cyclopropyl Fentanyl ............................................................................................................................................................... Cyclopentyl fentanyl ................................................................................................................................................................ Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ............................................................................................. Amphetamine ........................................................................................................................................................................... Methamphetamine ................................................................................................................................................................... Lisdexamfetamine .................................................................................................................................................................... Phenmetrazine ......................................................................................................................................................................... Methylphenidate ...................................................................................................................................................................... Amobarbital .............................................................................................................................................................................. VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 9606 9607 9608 9609 9611 9612 9613 9615 9616 9617 9618 9619 9621 9622 9623 9624 9625 9626 9627 9628 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9811 9812 9813 9814 9815 9816 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9845 9847 9850 1100 1105 1205 1631 1724 2125 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II 10475 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Drug code Controlled substance Pentobarbital ............................................................................................................................................................................ Secobarbital ............................................................................................................................................................................. Glutethimide ............................................................................................................................................................................. Nabilone ................................................................................................................................................................................... 1-Phenylcyclohexylamine ........................................................................................................................................................ Phencyclidine ........................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................................. Phenylacetone ......................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ........................................................................................................................................ Alphaprodine ............................................................................................................................................................................ Anileridine ................................................................................................................................................................................ Cocaine .................................................................................................................................................................................... Codeine ................................................................................................................................................................................... Etorphine HCl .......................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................................ Oxycodone ............................................................................................................................................................................... Hydromorphone ....................................................................................................................................................................... Diphenoxylate .......................................................................................................................................................................... Ecgonine .................................................................................................................................................................................. Ethylmorphine .......................................................................................................................................................................... Hydrocodone ........................................................................................................................................................................... Levomethorphan ...................................................................................................................................................................... Levorphanol ............................................................................................................................................................................. Isomethadone .......................................................................................................................................................................... Meperidine ............................................................................................................................................................................... Meperidine intermediate-A ...................................................................................................................................................... Meperidine intermediate-B ...................................................................................................................................................... Meperidine intermediate-C ...................................................................................................................................................... Metazocine .............................................................................................................................................................................. Methadone ............................................................................................................................................................................... Methadone intermediate .......................................................................................................................................................... Metopon ................................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................................... Morphine .................................................................................................................................................................................. Oripavine ................................................................................................................................................................................. Thebaine .................................................................................................................................................................................. Dihydroetorphine ..................................................................................................................................................................... Levo-alphacetylmethadol ......................................................................................................................................................... Oxymorphone .......................................................................................................................................................................... Noroxymorphone ..................................................................................................................................................................... Phenazocine ............................................................................................................................................................................ Thiafentanil .............................................................................................................................................................................. Piminodine ............................................................................................................................................................................... Racemethorphan ..................................................................................................................................................................... Racemorphan .......................................................................................................................................................................... Alfentanil .................................................................................................................................................................................. Remifentanil ............................................................................................................................................................................. Sufentanil ................................................................................................................................................................................. Carfentanil ............................................................................................................................................................................... Tapentadol ............................................................................................................................................................................... Bezitramide .............................................................................................................................................................................. Fentanyl ................................................................................................................................................................................... Moramide-intermediate ............................................................................................................................................................ The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers. lotter on DSKBCFDHB2PROD with NOTICES Dated: February 3, 2020. William T. McDermott, Assistant Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–589] [FR Doc. 2020–03612 Filed 2–21–20; 8:45 am] ACTION: Notice of application. BILLING CODE 4410–09–P Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on DATES: VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II or before March 25, 2020. Such persons may also file a written request for a hearing on the application on or before March 25, 2020. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug ADDRESSES: Importer of Controlled Substances Application: PerkinElmer, Inc. 2270 2315 2550 7379 7460 7471 8333 8501 8603 9010 9020 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9250 9254 9260 9273 9300 9330 9333 9334 9648 9652 9668 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 Schedule E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10471-10475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03612]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-595]


Bulk Manufacturer of Controlled Substances Application: Chemtos, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 24, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 9, 2020, Chemtos, LLC, 16713 Picadilly Court, 
Round Rock, Texas 78664-8544 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)....       1233  I
Cathinone.............................       1235  I
Methcathinone.........................       1237  I
4-Fluoro-N-methylcathinone (4-FMC)....       1238  I
Pentedrone ([alpha]-                         1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                      1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).....       1249  I

[[Page 10472]]

 
Naphyrone.............................       1258  I
N-Ethylamphetamine....................       1475  I
N,N-Dimethylamphetamine...............       1480  I
Fenethylline..........................       1503  I
Aminorex..............................       1585  I
4-Methylaminorex (cis isomer).........       1590  I
Gamma Hydroxybutyric Acid.............       2010  I
Methaqualone..........................       2565  I
Mecloqualone..........................       2572  I
JWH-250 (1-Pentyl-3-(2-                      6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-              7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-       7010  I
 1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
 1H-indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-      7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-          7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-      7014  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-                       7019  I
 naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4-               7020  I
 fluorobenzyl)-1H-indazole-3-
 carboxamido)-3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-      7021  I
 (1-(4-fluorobenzyl)-1Hindazole-3-
 carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-            7023  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-             7024  I
 indazol-3-yl](naphthalen-1-
 yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl-1-         7025  I
 oxobutan-2-yl)-1-(5-fluropentyl)-1H-
 indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1-          7031  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-
 1H-indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-      7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-
 1H-indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-        7033  I
 1H-indazole-3-carboxamido)-3-
 methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-      7034  I
 fluoropentyl)-1H-indazole-3-
 carboxamido)-3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-       7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5-               7036  I
 fluoropentyl)-1H-indazole-3-
 carboxamido)-3,3-dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-                7041  I
 fluoropentyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-      7042  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-         7044  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4-          7047  I
 FLUOROBENZYL) (N-(adamantan-1-yl)-1-
 (4-fluorobenzyl)-1H-indazole-3-
 carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-         7048  I
 pentyl-1H-indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan-1-        7049  I
 yl)-1-(5-fluoropentyl)-1H-indazole-3-
 carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-                   7081  I
 methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5-               7083  I
 fluoropentyl)-N-(2-phenylpropan-2-yl)-
 1H-indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-       7085  I
 (2-phenylpropan-2-yl)-1H-pyrrolo[2,3-
 b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-           7089  I
 BUTINACA, 4-CN-CUMYL BINACA, CUMYL-
 4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-
 N-(2-phenylpropan-2-yl)-1H-indazole-3-
 carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-       7104  I
 3-[(4-methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-            7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-             7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-                 7144  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-                       7173  I
 naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-       7200  I
 (1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-             7201  I
 naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2-                      7203  I
 chlorophenylacetyl)indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-       7221  I
 fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-            7222  I
 indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                7225  I
 fluoropentyl)-1H-indole-3-
 carboxylate).
4-MEAP (4-Methyl-alpha-                      7245  I
 ethylaminopentiophenone).
N-Ethylhexedrone......................       7246  I
Alpha-ethyltryptamine.................       7249  I
Ibogaine..............................       7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-         7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-              7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide............       7315  I
2,5-Dimethoxy-4-(n)-                         7348  I
 propylthiophenethylamine (2C-T-7).
Marihuana Extract.....................       7350  I
Marihuana.............................       7360  I
Parahexyl.............................       7374  I
Mescaline.............................       7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)          7385  I
 ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine...........       7390  I
4-Bromo-2,5-dimethoxyamphetamine......       7391  I
4-Bromo-2,5-dimethoxyphenethylamine...       7392  I
4-Methyl-2,5-dimethoxyamphetamine.....       7395  I
2,5-Dimethoxyamphetamine..............       7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-             7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine......       7399  I
3,4-Methylenedioxyamphetamine.........       7400  I
5-Methoxy-3,4-                               7401  I
 methylenedioxyamphetamine.
N-Hydroxy-3,4-                               7402  I
 methylenedioxyamphetamine.

[[Page 10473]]

 
3,4-Methylenedioxy-N-ethylamphetamine.       7404  I
3,4-Methylenedioxymethamphetamine.....       7405  I
4-Methoxyamphetamine..................       7411  I
5-Methoxy-N-N-dimethyltryptamine......       7431  I
Alpha-methyltryptamine................       7432  I
Bufotenine............................       7433  I
Diethyltryptamine.....................       7434  I
Dimethyltryptamine....................       7435  I
Psilocybin............................       7437  I
Psilocyn..............................       7438  I
5-Methoxy-N,N-diisopropyltryptamine...       7439  I
4'-Chloro-alpha-                             7443  I
 pyrrolidinovalerophenone.
MPHP, 4'-Methyl-alpha-                       7446  I
 pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine.......       7455  I
1-(1-Phenylcyclohexyl)pyrrolidine.....       7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine.       7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine       7473  I
N-Ethyl-3-piperidyl benzilate.........       7482  I
N-Methyl-3-piperidyl benzilate........       7484  I
N-Benzylpiperazine....................       7493  I
4-Methyl-alphapyrrolidinopropiophenone       7498  I
 (4-MePPP).
2-(2,5-Dimethoxy-4-                          7508  I
 methylphenyl)ethanamine (2C-D).
2-(2,5-Dimethoxy-4-                          7509  I
 ethylphenyl)ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl)ethanamine (2C-       7517  I
 H).
2-(4-iodo-2,5-                               7518  I
 dimethoxyphenyl)ethanamine (2C-I).
2-(4-Chloro-2,5-                             7519  I
 dimethoxyphenyl)ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-                    7521  I
 phenyl)ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-                      7524  I
 propylphenyl)ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-                     7532  I
 dimethoxyphenyl)ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone).       7535  I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-        7536  I
 methoxybenzyl)ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-       7537  I
 methoxybenzyl)ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-         7538  I
 methoxybenzyl)ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N-             7540  I
 methylcathinone).
Butylone..............................       7541  I
Pentylone.............................       7542  I
N-Ethypentylone, ephylone (1-(1,3-           7543  I
 benzodioxol-5-yl)-2-(ethylamino)-
 pentan-1-one).
[alpha]-PHP, alpha-                          7544  I
 Pyrrolidinohexanophenone.
alpha-pyrrolidinopentiophenone               7545  I
 ([alpha]-PVP).
alpha-pyrrolidinobutiophenone ([alpha]-      7546  I
 PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-             7694  I
 iodobenzoyl)indole).
Acetyldihydrocodeine..................       9051  I
Benzylmorphine........................       9052  I
Codeine-N-oxide.......................       9053  I
Cyprenorphine.........................       9054  I
Desomorphine..........................       9055  I
Etorphine (except HCl)................       9056  I
Codeine methylbromide.................       9070  I
Dihydromorphine.......................       9145  I
Difenoxin.............................       9168  I
Heroin................................       9200  I
Hydromorphinol........................       9301  I
Methyldesorphine......................       9302  I
Methyldihydromorphine.................       9304  I
Morphine methylbromide................       9305  I
Morphine methylsulfonate..............       9306  I
Morphine-N-oxide......................       9307  I
Myrophine.............................       9308  I
Nicocodeine...........................       9309  I
Nicomorphine..........................       9312  I
Normorphine...........................       9313  I
Pholcodine............................       9314  I
Thebacon..............................       9315  I
Acetorphine...........................       9319  I
Drotebanol............................       9335  I
U-47700 (3,4-dichloro-N-[2-                  9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                 9551  I
 dimethylamino)cyclohexylmethyl]benzam
 ide)).
MT-45 (1-cyclohexyl-4-(1,2-                  9560  I
 diphenylethyl)piperazine)).
Acetylmethadol........................       9601  I
Allylprodine..........................       9602  I
Alphacetylmethadol except levo-              9603  I
 alphacetylmethadol.
Alphameprodine........................       9604  I
Alphamethadol.........................       9605  I

[[Page 10474]]

 
Benzethidine..........................       9606  I
Betacetylmethadol.....................       9607  I
Betameprodine.........................       9608  I
Betamethadol..........................       9609  I
Betaprodine...........................       9611  I
Clonitazene...........................       9612  I
Dextromoramide........................       9613  I
Diampromide...........................       9615  I
Diethylthiambutene....................       9616  I
Dimenoxadol...........................       9617  I
Dimepheptanol.........................       9618  I
Dimethylthiambutene...................       9619  I
Dioxaphetyl butyrate..................       9621  I
Dipipanone............................       9622  I
Ethylmethylthiambutene................       9623  I
Etonitazene...........................       9624  I
Etoxeridine...........................       9625  I
Furethidine...........................       9626  I
Hydroxypethidine......................       9627  I
Ketobemidone..........................       9628  I
Levomoramide..........................       9629  I
Levophenacylmorphan...................       9631  I
Morpheridine..........................       9632  I
Noracymethadol........................       9633  I
Norlevorphanol........................       9634  I
Normethadone..........................       9635  I
Norpipanone...........................       9636  I
Phenadoxone...........................       9637  I
Phenampromide.........................       9638  I
Phenoperidine.........................       9641  I
Piritramide...........................       9642  I
Proheptazine..........................       9643  I
Properidine...........................       9644  I
Racemoramide..........................       9645  I
Trimeperidine.........................       9646  I
Phenomorphan..........................       9647  I
Propiram..............................       9649  I
1-Methyl-4-phenyl-4-                         9661  I
 propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4-                9663  I
 acetoxypiperidine.
Tilidine..............................       9750  I
Acryl fentanyl (N-(1-                        9811  I
 phenethylpiperidin-4-yl)-N-
 phenylacrylamide).
Para-Fluorofentanyl...................       9812  I
3-Methylfentanyl......................       9813  I
Alpha-methylfentanyl..................       9814  I
Acetyl-alpha-methylfentanyl...........       9815  I
N-(2-fluorophenyl)-N-(1-                     9816  I
 phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1-                       9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Butyryl Fentanyl......................       9822  I
Para-fluorobutyryl fentanyl...........       9823  I
4-Fluoroisobutyryl fentanyl (N-(4-           9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-
 4-yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-         9825  I
 yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl........       9826  I
Isobutyryl fentanyl...................       9827  I
Beta-hydroxyfentanyl..................       9830  I
Beta-hydroxy-3-methylfentanyl.........       9831  I
Alpha-methylthiofentanyl..............       9832  I
3-Methylthiofentanyl..................       9833  I
Furanyl fentanyl (N-(1-                      9834  I
 phenethylpiperidin-4-yl)-N-
 phenylfuran-2-carboxamide).
Thiofentanyl..........................       9835  I
Beta-hydroxythiofentanyl..............       9836  I
Para-methoxybutyryl fentanyl..........       9837  I
Para-methoxybutyryl fentanyl..........       9838  I
Valeryl fentanyl......................       9840  I
N-(1-phenethylpiperidin-4-yl)-N-             9843  I
 phenyltetrahydrofuran-2-carboxamide.
Cyclopropyl Fentanyl..................       9845  I
Cyclopentyl fentanyl..................       9847  I
Fentanyl related-compounds as defined        9850  I
 in 21 CFR 1308.11(h).
Amphetamine...........................       1100  II
Methamphetamine.......................       1105  II
Lisdexamfetamine......................       1205  II
Phenmetrazine.........................       1631  II
Methylphenidate.......................       1724  II
Amobarbital...........................       2125  II

[[Page 10475]]

 
Pentobarbital.........................       2270  II
Secobarbital..........................       2315  II
Glutethimide..........................       2550  II
Nabilone..............................       7379  II
1-Phenylcyclohexylamine...............       7460  II
Phencyclidine.........................       7471  II
4-Anilino-N-phenethyl-4-piperidine           8333  II
 (ANPP).
Phenylacetone.........................       8501  II
1-Piperidinocyclohexanecarbonitrile...       8603  II
Alphaprodine..........................       9010  II
Anileridine...........................       9020  II
Cocaine...............................       9041  II
Codeine...............................       9050  II
Etorphine HCl.........................       9059  II
Dihydrocodeine........................       9120  II
Oxycodone.............................       9143  II
Hydromorphone.........................       9150  II
Diphenoxylate.........................       9170  II
Ecgonine..............................       9180  II
Ethylmorphine.........................       9190  II
Hydrocodone...........................       9193  II
Levomethorphan........................       9210  II
Levorphanol...........................       9220  II
Isomethadone..........................       9226  II
Meperidine............................       9230  II
Meperidine intermediate-A.............       9232  II
Meperidine intermediate-B.............       9233  II
Meperidine intermediate-C.............       9234  II
Metazocine............................       9240  II
Methadone.............................       9250  II
Methadone intermediate................       9254  II
Metopon...............................       9260  II
Dextropropoxyphene, bulk (non-dosage         9273  II
 forms).
Morphine..............................       9300  II
Oripavine.............................       9330  II
Thebaine..............................       9333  II
Dihydroetorphine......................       9334  II
Levo-alphacetylmethadol...............       9648  II
Oxymorphone...........................       9652  II
Noroxymorphone........................       9668  II
Phenazocine...........................       9715  II
Thiafentanil..........................       9729  II
Piminodine............................       9730  II
Racemethorphan........................       9732  II
Racemorphan...........................       9733  II
Alfentanil............................       9737  II
Remifentanil..........................       9739  II
Sufentanil............................       9740  II
Carfentanil...........................       9743  II
Tapentadol............................       9780  II
Bezitramide...........................       9800  II
Fentanyl..............................       9801  II
Moramide-intermediate.................       9802  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances in bulk for distribution to its customers.

    Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03612 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P